JP2022538425A5 - - Google Patents

Info

Publication number
JP2022538425A5
JP2022538425A5 JP2021576820A JP2021576820A JP2022538425A5 JP 2022538425 A5 JP2022538425 A5 JP 2022538425A5 JP 2021576820 A JP2021576820 A JP 2021576820A JP 2021576820 A JP2021576820 A JP 2021576820A JP 2022538425 A5 JP2022538425 A5 JP 2022538425A5
Authority
JP
Japan
Prior art keywords
cancer
immune cell
antigen
receptor
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021576820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538425A (ja
JP7829911B2 (ja
Filing date
Publication date
Priority claimed from PCT/KR2019/010244 external-priority patent/WO2020032784A1/ko
Application filed filed Critical
Priority claimed from PCT/IB2020/056097 external-priority patent/WO2020261231A1/en
Publication of JP2022538425A publication Critical patent/JP2022538425A/ja
Publication of JP2022538425A5 publication Critical patent/JP2022538425A5/ja
Priority to JP2025076601A priority Critical patent/JP2025118764A/ja
Application granted granted Critical
Publication of JP7829911B2 publication Critical patent/JP7829911B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021576820A 2019-06-27 2020-06-26 4-1bb共刺激性ドメインを有するキメラ抗原受容体 Active JP7829911B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076601A JP2025118764A (ja) 2019-06-27 2025-05-02 4-1bb共刺激性ドメインを有するキメラ抗原受容体

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201962867503P 2019-06-27 2019-06-27
US62/867,503 2019-06-27
PCT/KR2019/010244 WO2020032784A1 (ko) 2018-08-10 2019-08-12 Hla-dr에 결합하는 키메라 항원 수용체 및 car-t 세포
KRPCT/KR2019/010244 2019-08-12
US16/715,462 2019-12-16
US16/715,462 US11013765B2 (en) 2018-08-10 2019-12-16 Chimeric antigen receptor that binds HLA-DR and CAR-T cell
US202062991493P 2020-03-18 2020-03-18
US62/991,493 2020-03-18
US202063004827P 2020-04-03 2020-04-03
US63/004,827 2020-04-03
US202063043237P 2020-06-24 2020-06-24
US63/043,237 2020-06-24
PCT/IB2020/056097 WO2020261231A1 (en) 2019-06-27 2020-06-26 Chimeric antigen receptor with 4-1bb costimulatory domain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076601A Division JP2025118764A (ja) 2019-06-27 2025-05-02 4-1bb共刺激性ドメインを有するキメラ抗原受容体

Publications (3)

Publication Number Publication Date
JP2022538425A JP2022538425A (ja) 2022-09-02
JP2022538425A5 true JP2022538425A5 (cg-RX-API-DMAC7.html) 2023-06-15
JP7829911B2 JP7829911B2 (ja) 2026-03-16

Family

ID=74061779

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021576820A Active JP7829911B2 (ja) 2019-06-27 2020-06-26 4-1bb共刺激性ドメインを有するキメラ抗原受容体
JP2025076601A Withdrawn JP2025118764A (ja) 2019-06-27 2025-05-02 4-1bb共刺激性ドメインを有するキメラ抗原受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076601A Withdrawn JP2025118764A (ja) 2019-06-27 2025-05-02 4-1bb共刺激性ドメインを有するキメラ抗原受容体

Country Status (9)

Country Link
EP (1) EP3990626A4 (cg-RX-API-DMAC7.html)
JP (2) JP7829911B2 (cg-RX-API-DMAC7.html)
KR (1) KR102957801B1 (cg-RX-API-DMAC7.html)
CN (2) CN114080452B (cg-RX-API-DMAC7.html)
AU (1) AU2020307673A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021026406A2 (cg-RX-API-DMAC7.html)
CA (1) CA3144875A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021015967A (cg-RX-API-DMAC7.html)
WO (1) WO2020261231A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7539161B2 (ja) * 2018-08-10 2024-08-23 ユーティレックス カンパニー リミテッド Hla-drに結合するキメラ抗原受容体およびcar-t細胞
JP7711945B2 (ja) 2019-04-30 2025-07-23 センティ バイオサイエンシズ インコーポレイテッド キメラ受容体及びその使用方法
KR102671410B1 (ko) * 2021-03-03 2024-06-04 진화섭 RANK 리간드(RANK ligand)에 특이적으로 결합하는 키메릭 항원 수용체 및 이의 용도
US20250195572A1 (en) * 2022-03-15 2025-06-19 New York Genome Center, Inc. Methods and compositions comprising fusion proteins for improved immunotherapies
KR20260113096A (ko) * 2023-11-16 2026-07-21 리포진 메디슨 키메라 항원 수용체 및 그 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050113564A1 (en) * 2003-11-05 2005-05-26 St. Jude Children's Research Hospital Chimeric receptors with 4-1BB stimulatory signaling domain
JP4331227B2 (ja) * 2004-07-09 2009-09-16 中外製薬株式会社 抗グリピカン3抗体
AU2013204922B2 (en) * 2012-12-20 2015-05-14 Celgene Corporation Chimeric antigen receptors
US9790282B2 (en) * 2013-03-25 2017-10-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
EP3066118B1 (en) * 2013-11-06 2020-01-08 The U.S.A. as represented by the Secretary, Department of Health and Human Services Alk antibodies, conjugates, and chimeric antigen receptors, and their use
KR101605421B1 (ko) * 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
ES2836743T3 (es) * 2014-06-02 2021-06-28 Us Health Receptores de antígeno quiméricos que seleccionan como diana CD-19
US10195272B2 (en) * 2015-03-02 2019-02-05 The Nemours Foundation Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases
CA2987992A1 (en) * 2015-06-04 2016-12-08 University Of Southern California Lym-1 and lym-2 targeted car cell immunotherapy
ES2778651T3 (es) * 2015-10-09 2020-08-11 Miltenyi Biotec Technology Inc Receptores de antígeno quimérico y métodos de uso
CN105906720A (zh) * 2016-05-16 2016-08-31 武汉汉密顿生物科技股份有限公司 靶向性嵌合抗原受体修饰的免疫细胞及其制备方法和应用
CN106279438B (zh) * 2016-08-24 2019-10-22 北京领柯生物科技有限公司 新型嵌合抗原受体及其用途
CN108165568B (zh) * 2016-12-07 2020-12-08 上海恒润达生生物科技有限公司 一种培养CD19CAR-iNKT细胞方法及用途
US11286306B2 (en) * 2016-12-09 2022-03-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. TLR9-binding chimeric antigen receptors
EP3568406A4 (en) * 2017-01-10 2020-10-21 The General Hospital Corporation T LYMPHOCYTES EXPRESSING A CHEMERICAL ANTIGENIC RECEPTOR
EP3568469A4 (en) * 2017-02-21 2020-11-11 Eutilex Co., Ltd. COMPOSITIONS OF CAR-T CELLS DIRECTED AGAINST HLA-DR AND THEIR MANUFACTURING AND USE PROCEDURES
US12083148B2 (en) * 2017-02-22 2024-09-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. IL13Ra2-binding chimeric antigen receptors
CN108728459B (zh) * 2017-04-24 2023-08-04 上海恒润达生生物科技股份有限公司 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途
WO2018236909A1 (en) * 2017-06-20 2018-12-27 La Jolla Institute For Allergy And Immunology T-MODIFIED LYMPHOCYTE RECEPTORS AND METHODS OF USE IN INFLAMMATORY RESPONMS MODULATION AND ATHEROSCLEROSIS TREATMENT
AU2018309735B2 (en) * 2017-07-31 2025-03-13 Lentigen Technology, Inc. Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
CN108715859B (zh) * 2018-05-31 2021-08-03 中国医学科学院血液病医院(中国医学科学院血液学研究所) 靶向cd22的嵌合抗原受体及其应用
WO2020017479A1 (ja) * 2018-07-17 2020-01-23 ノイルイミューン・バイオテック株式会社 抗gpc3一本鎖抗体を含むcar

Similar Documents

Publication Publication Date Title
JP2021520788A5 (cg-RX-API-DMAC7.html)
JP2021000103A5 (cg-RX-API-DMAC7.html)
KR102879284B1 (ko) 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
AU2018204209C1 (en) Method and compositions for cellular immunotherapy
JP2022523781A5 (cg-RX-API-DMAC7.html)
JP2019516352A5 (cg-RX-API-DMAC7.html)
HRP20221348T1 (hr) Kimerni receptori i postupci njihove uporabe
JP2020513839A5 (cg-RX-API-DMAC7.html)
JP2021530233A5 (cg-RX-API-DMAC7.html)
US11725053B2 (en) Chimeric antigen receptors comprising a human transferrin epitope sequence
JP2017522879A5 (cg-RX-API-DMAC7.html)
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JP2019525771A5 (cg-RX-API-DMAC7.html)
JP2023518930A5 (cg-RX-API-DMAC7.html)
JP2018527014A5 (cg-RX-API-DMAC7.html)
RU2019128921A (ru) Антитело к il-13ra2 и его применение
JP2024539506A5 (cg-RX-API-DMAC7.html)
JP2019516350A5 (cg-RX-API-DMAC7.html)
WO2022157500A1 (en) Methods for high throughput screening of chimeric antigen receptors
JP2024517027A5 (cg-RX-API-DMAC7.html)
JP2025513427A5 (cg-RX-API-DMAC7.html)
JP2025511409A5 (cg-RX-API-DMAC7.html)
CN113474012A (zh) Epcam抗体和epcam-car-t细胞
JP2023518931A5 (cg-RX-API-DMAC7.html)
JP2024516748A5 (cg-RX-API-DMAC7.html)